MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Grüner, Barbara M ^a   Hahne, Hannes ^a   Mazur, Pawel K ^a,d   Trajkovic Arsic, Marija ^a   Maier, Stefan ^a,b   Esposito, Irene ^a,b   Kalideris, Evdokia ^a   Michalski, Christoph W ^a   Kleeff, Jörg ^a   Rauser, Sandra ^b   Schmid, Roland M ^a   Küster, Bernhard ^a,c   Walch, Axel ^b   Siveke, Jens T ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b INSTITUTE OF EPIDEMIOLOGY   (Germany)

^c Munich Center for Integrated Protein Science   (Germany)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; THYMOSIN BETA4;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER TISSUE; CELL TRANSDIFFERENTIATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION IMAGING MASS SPECTROMETRY; MOUSE; NONHUMAN; OPTICAL RESOLUTION; PANCREAS ADENOCARCINOMA; PANCREAS ADENOMA; PRECANCER; PROTEIN ANALYSIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PROTEOMICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TANDEM MASS SPECTROMETRY; UPREGULATION; WESTERN BLOTTING;

AGED; ANIMALS; CARCINOMA, PANCREATIC DUCTAL; FEMALE; HUMANS; MALE; MICE; MICE, TRANSGENIC; MIDDLE AGED; PANCREAS; PANCREATIC NEOPLASMS; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TUMOR MARKERS, BIOLOGICAL;

EID: 84862729941     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039424     Document Type: Article

References (49)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, et al. (2008) Cancer statistics, 2008. CA Cancer J Clin 58: 71-96.
2. Schneider G, Siveke JT, Eckel F, Schmid RM, (2005) Pancreatic cancer: basic and clinical aspects. Gastroenterology 128: 1606-1625.
3. Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, Depinho RA, (2006) Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20: 1218-1249.
4. Canto MI, Goggins M, Hruban RH, Petersen GM, Giardiello FM, et al. (2006) Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study. Clin Gastroenterol Hepatol 4: 766-781; quiz 665.
5. Hruban RH, Takaori K, Klimstra DS, Adsay NV, Albores-Saavedra J, et al. (2004) An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol 28: 977-987.
6. Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, et al. (2006) Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66: 95-106.
7. Hingorani SR, Petricoin EF, Maitra A, Rajapakse V, King C, et al. (2003) Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse. Cancer Cell 4: 437-450.
8. Siveke JT, Einwachter H, Sipos B, Lubeseder-Martellato C, Kloppel G, et al. (2007) Concomitant pancreatic activation of Kras(G12D) and Tgfa results in cystic papillary neoplasms reminiscent of human IPMN. Cancer Cell 12: 266-279.
9. Schwamborn K, Caprioli RM, (2010) Molecular imaging by mass spectrometry-looking beyond classical histology. Nat Rev Cancer 10: 639-646.
10. Pierson J, Norris JL, Aerni HR, Svenningsson P, Caprioli RM, et al. (2004) Molecular profiling of experimental Parkinson's disease: direct analysis of peptides and proteins on brain tissue sections by MALDI mass spectrometry. J Proteome Res 3: 289-295.
11. Stoeckli M, Staab D, Staufenbiel M, Wiederhold KH, Signor L, (2002) Molecular imaging of amyloid beta peptides in mouse brain sections using mass spectrometry. Anal Biochem 311: 33-39.
12. Chaurand P, Schwartz SA, Billheimer D, Xu BJ, Crecelius A, et al. (2004) Integrating histology and imaging mass spectrometry. Anal Chem 76: 1145-1155.
13. Stoeckli M, Chaurand P, Hallahan DE, Caprioli RM, (2001) Imaging mass spectrometry: a new technology for the analysis of protein expression in mammalian tissues. Nat Med 7: 493-496.
14. Schwartz SA, Weil RJ, Johnson MD, Toms SA, Caprioli RM, (2004) Protein profiling in brain tumors using mass spectrometry: feasibility of a new technique for the analysis of protein expression. Clin Cancer Res 10: 981-987.
15. Schwartz SA, Weil RJ, Thompson RC, Shyr Y, Moore JH, et al. (2005) Proteomic-based prognosis of brain tumor patients using direct-tissue matrix-assisted laser desorption ionization mass spectrometry. Cancer Res 65: 7674-7681.
16. Lemaire R, Menguellet SA, Stauber J, Marchaudon V, Lucot JP, et al. (2007) Specific MALDI imaging and profiling for biomarker hunting and validation: fragment of the 11S proteasome activator complex, Reg alpha fragment, is a new potential ovary cancer biomarker. J Proteome Res 6: 4127-4134.
17. Cazares LH, Troyer D, Mendrinos S, Lance RA, Nyalwidhe JO, et al. (2009) Imaging mass spectrometry of a specific fragment of mitogen-activated protein kinase/extracellular signal-regulated kinase kinase kinase 2 discriminates cancer from uninvolved prostate tissue. Clin Cancer Res 15: 5541-5551.
18. Cornett DS, Mobley JA, Dias EC, Andersson M, Arteaga CL, et al. (2006) A novel histology-directed strategy for MALDI-MS tissue profiling that improves throughput and cellular specificity in human breast cancer. Mol Cell Proteomics 5: 1975-1983.
19. Chaurand P, DaGue BB, Pearsall RS, Threadgill DW, Caprioli RM, (2001) Profiling proteins from azoxymethane-induced colon tumors at the molecular level by matrix-assisted laser desorption/ionization mass spectrometry. Proteomics 1: 1320-1326.
20. Walch A, Rauser S, Deininger SO, Hofler H, (2008) MALDI imaging mass spectrometry for direct tissue analysis: a new frontier for molecular histology. Histochem Cell Biol 130: 421-434.
21. Nakhai H, Sel S, Favor J, Mendoza-Torres L, Paulsen F, et al. (2007) Ptf1a is essential for the differentiation of GABAergic and glycinergic amacrine cells and horizontal cells in the mouse retina. Development 134: 1151-1160.
22. Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL, Lee DC, (1990) Overexpression of TGF alpha in transgenic mice: induction of epithelial hyperplasia, pancreatic metaplasia, and carcinoma of the breast. Cell 61: 1121-1135.
23. Hingorani SR, Wang L, Multani AS, Combs C, Deramaudt TB, et al. (2005) Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice. Cancer Cell 7: 469-483.
24. Cha HJ, Philp D, Lee SH, Moon HS, Kleinman HK, et al. (2010) Over-expression of thymosin beta 4 promotes abnormal tooth development and stimulation of hair growth. Int J Dev Biol 54: 135-140.
25. Spurney CF, Cha HJ, Sali A, Pandey GS, Pistilli E, et al. (2010) Evaluation of skeletal and cardiac muscle function after chronic administration of thymosin beta-4 in the dystrophin deficient mouse. PLoS One 5: e8976.
26. Reddy JK, Rao MS, Qureshi SA, Reddy MK, Scarpelli DG, et al. (1984) Induction and origin of hepatocytes in rat pancreas. J Cell Biol 98: 2082-2090.
27. Dabeva MD, Hurston E, Shafritz DA, (1995) Transcription factor and liver-specific mRNA expression in facultative epithelial progenitor cells of liver and pancreas. Am J Pathol 147: 1633-1648.
28. Paner GP, Thompson KS, Reyes CV, (2000) Hepatoid carcinoma of the pancreas. Cancer 88: 1582-1589.
29. Cingolani N, Shaco-Levy R, Farruggio A, Klimstra DS, Rosai J, (2000) Alpha-fetoprotein production by pancreatic tumors exhibiting acinar cell differentiation: study of five cases, one arising in a mediastinal teratoma. Hum Pathol 31: 938-944.
30. Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, et al. (2008) A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med 5: e123.
31. Taguchi A, Politi K, Pitteri SJ, Lockwood WW, Faca VM, et al. (2011) Lung cancer signatures in plasma based on proteome profiling of mouse tumor models. Cancer Cell 20: 289-299.
32. Meistermann H, Norris JL, Aerni HR, Cornett DS, Friedlein A, et al. (2006) Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in rat. Mol Cell Proteomics 5: 1876-1886.
33. Yanagisawa K, Shyr Y, Xu BJ, Massion PP, Larsen PH, et al. (2003) Proteomic patterns of tumour subsets in non-small-cell lung cancer. Lancet 362: 433-439.
34. Reyzer ML, Hsieh Y, Ng K, Korfmacher WA, Caprioli RM, (2003) Direct analysis of drug candidates in tissue by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom 38: 1081-1092.
35. Reyzer ML, Caldwell RL, Dugger TC, Forbes JT, Ritter CA, et al. (2004) Early changes in protein expression detected by mass spectrometry predict tumor response to molecular therapeutics. Cancer Res 64: 9093-9100.
36. Caprioli RM, (2005) Deciphering protein molecular signatures in cancer tissues to aid in diagnosis, prognosis, and therapy. Cancer Res 65: 10642-10645.
37. Jaskolla TW, Karas M, Roth U, Steinert K, Menzel C, et al. (2009) Comparison between vacuum sublimed matrices and conventional dried droplet preparation in MALDI-TOF mass spectrometry. J Am Soc Mass Spectrom 20: 1104-1114.
38. Watrous JD, Alexandrov T, Dorrestein PC, (2011) The evolving field of imaging mass spectrometry and its impact on future biological research. J Mass Spectrom 46: 209-222.
39. Zhang Y, Feurino LW, Zhai Q, Wang H, Fisher WE, et al. (2008) Thymosin Beta 4 is overexpressed in human pancreatic cancer cells and stimulates proinflammatory cytokine secretion and JNK activation. Cancer Biol Ther 7: 419-423.
40. Paciucci R, Berrozpe G, Tora M, Navarro E, Garcia de Herreros A, et al. (1996) Isolation of tissue-type plasminogen activator, cathepsin H, and non-specific cross-reacting antigen from SK-PC-1 pancreas cancer cells using subtractive hybridization. FEBS Lett 385: 72-76.
41. Nemolato S, Cabras T, Cau F, Fanari MU, Fanni D, et al. (2010) Different thymosin Beta 4 immunoreactivity in foetal and adult gastrointestinal tract. PLoS One 5: e9111.
42. Smart N, Risebro CA, Melville AA, Moses K, Schwartz RJ, et al. (2007) Thymosin beta4 induces adult epicardial progenitor mobilization and neovascularization. Nature 445: 177-182.
43. Djidja MC, Claude E, Snel MF, Scriven P, Francese S, et al. (2009) MALDI-ion mobility separation-mass spectrometry imaging of glucose-regulated protein 78 kDa (Grp78) in human formalin-fixed, paraffin-embedded pancreatic adenocarcinoma tissue sections. J Proteome Res 8: 4876-4884.
44. Lukie BE, (1986) Serum protein content of rat small-intestinal mucus. Dig Dis Sci 31: 73-78.
45. Kim N, Yoo W, Lee J, Kim H, Lee H, et al. (2009) Formation of vitamin A lipid droplets in pancreatic stellate cells requires albumin. Gut 58: 1382-1390.
46. Lardon J, De Breuck S, Rooman I, Van Lommel L, Kruhoffer M, et al. (2004) Plasticity in the adult rat pancreas: transdifferentiation of exocrine to hepatocyte-like cells in primary culture. Hepatology 39: 1499-1507.
47. Shen CN, Seckl JR, Slack JM, Tosh D, (2003) Glucocorticoids suppress beta-cell development and induce hepatic metaplasia in embryonic pancreas. Biochem J 375: 41-50.
48. Shen CN, Slack JM, Tosh D, (2000) Molecular basis of transdifferentiation of pancreas to liver. Nat Cell Biol 2: 879-887.
49. Masui T, Swift GH, Deering T, Shen C, Coats WS, et al. (2010) Replacement of Rbpj with Rbpjl in the PTF1 complex controls the final maturation of pancreatic acinar cells. Gastroenterology 139: 270-280.